Interim Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes. J of Skin 2022, 6 (6), 458-462. https://doi.org/10.25251/skin.6.6.2.